Vanderbilt Television News Archive

Search the Archive

Commercial: diabetic ketoacidosis / A1C #1253604

NBC Evening News for Tuesday, Oct 22, 2019
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws. For any such use, please visit NBC NEWS Archives XPRESS.

My body is truly powerful. I have the power, to lower my blood sugar and A1C. Because I can still make my own insulin. And Trulicity activates my body to release it. Like it's supposed to. Trulicity, is for people with type two diabetes. It's not insulin. I take a once a week. It starts acting in my body from the first dose. Trulicity isn't for people with type one diabetes or diabetic ketoacidosis. Don't take Trulicity you're allergic to it. You and your family have medullary thyroid cancer or ...
Duration:
00:00:59

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.